Cyclerion Therapeutics Inc (CYCN)
3.00
0.00 (0.00%)
USD |
NASDAQ |
May 10, 16:00
3.00
0.00 (0.00%)
After-Hours: 20:00
Cyclerion Therapeutics Cash from Operations (TTM): -21.24M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -21.24M |
September 30, 2023 | -26.75M |
June 30, 2023 | -29.73M |
March 31, 2023 | -33.99M |
December 31, 2022 | -40.61M |
September 30, 2022 | -42.20M |
June 30, 2022 | -40.21M |
March 31, 2022 | -34.90M |
December 31, 2021 | -36.52M |
September 30, 2021 | -41.93M |
June 30, 2021 | -49.05M |
Date | Value |
---|---|
March 31, 2021 | -57.76M |
December 31, 2020 | -72.49M |
September 30, 2020 | -80.61M |
June 30, 2020 | -89.38M |
March 31, 2020 | -97.12M |
December 31, 2019 | -102.22M |
September 30, 2019 | -103.20M |
June 30, 2019 | -104.70M |
March 31, 2019 | -105.34M |
December 31, 2018 | -97.50M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-104.70M
Minimum
Jun 2019
-21.24M
Maximum
Dec 2023
-58.14M
Average
-42.20M
Median
Sep 2022
Cash from Operations (TTM) Benchmarks
Eli Lilly and Co | 3.676B |
iBio Inc | -18.89M |
AbbVie Inc | 22.69B |
Agile Therapeutics Inc | -9.577M |
NovaBay Pharmaceuticals Inc | -4.131M |